BERLIN - German health technology company Siemens Healthineers said Thursday its revenues in the fiscal year 2021 that ended on Sept 30 rose by 19.3 percent year-on-year to reach the record figure of almost 18 billion euros ($20.7 billion) on a comparable basis. The contribution to sales from rapid COVID-19 antigen tests was around 1.1 billion euros. Without these, there would only be comparable total revenue growth of 11.8 percent, according to the company. After 1.4 billion euros last year, net income of Siemens Healthineers was now as high as 1.7 billion euros, it said. Siemens Healthineers "successfully ended the